Erlotinib Hydrochloride With or Without Bevacizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations
PHASE2
This randomized phase II trial studies how well erlotinib hydrochloride (Ta...
Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive and Estrogen Receptor/Progesterone Receptor Negative Breast Cancer to Evaluate the Efficiency and Safety of Treatment With Trastuzumab Plus (+) QL1209/Pertuzumab + Docetaxel.
PHASE3
This is a randomized, double-blind, multicenter trial,parallel control desi...
A Global Phase II/III Clinical Study to Evaluate the Efficacy and Safety of HLX43 Monotherapy or HLX43 in Combination With HLX07 Versus Docetaxel in Advanced or Metastatic Squamous Non-Small Cell Lung Cancer
PHASE2
This is a randomized, open-label, multi-center, global phase II/III clinica...
Status
Recruiting
Location
Cancer Hospital, Chinese Academy of Medical Sciences
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
PHASE3
This phase III trial compares hepatic arterial infusion (HAI) (pump chemoth...